After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA)Zacks Investment Research • 06/07/24
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street AnalystThe Motley Fool • 05/20/24
Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in JapanPRNewsWire • 05/14/24
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/09/24
GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel SweetenerPRNewsWire • 05/07/24
Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual MeetingPRNewsWire • 05/06/24